NCT00030121

Brief Summary

The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1999

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 1, 2002

Completed
Last Updated

February 20, 2008

Status Verified

February 1, 2008

First QC Date

January 31, 2002

Last Update Submit

February 19, 2008

Conditions

Respiratory Distress Syndrome

Keywords

Acute Respiratory DistressAcute Lung Injury

Interventions

recombinant human atrial natriuretic polypeptideDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • In order to participate in the study, patients must:
  • be 18 years or older
  • have an acceptable PF ratio
  • have adequate fluid volume
  • be intubated less than 7 days

You may not qualify if:

  • In order to participate in the study, patients must not meet any of the following criteria:
  • be moribund
  • be immunocompromised
  • have pneumonia (caused by Pneumocystis carinii)
  • have recieved another investigational drug or device within the last 30 days
  • have a Do not Resuscitate order

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Distress SyndromeAcute Lung Injury

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersLung Injury

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 31, 2002

First Posted

February 1, 2002

Study Start

December 1, 1999

Last Updated

February 20, 2008

Record last verified: 2008-02